Inhaled and nasal corticosteroids: safety aspects.
Passalacqua
G
G
Allergy and Respiratory Diseases, DIMI, Department of Internal Medicine, Genoa, Italy.
Albano
M
M
Canonica
G W
GW
Bachert
C
C
Van Cauwenberge
P
P
Davies
R J
RJ
Durham
S R
SR
Kontou-Fili
K
K
Horak
F
F
Malling
H J
HJ
D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D001249:Asthma / Q000628:therapy*; D001851:Bone Diseases, Metabolic / Q000139:chemically induced; D001986:Bronchial Spasm / Q000139:chemically induced; D002180:Candidiasis, Oral / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D003371:Cough / Q000139:chemically induced; D005260:Female; D006128:Growth / Q000187:drug effects; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007223:Infant; D007231:Infant, Newborn; D010913:Pituitary-Adrenal System / Q000187:drug effects; D011247:Pregnancy; D012220:Rhinitis / Q000628:therapy*; D014832:Voice Disorders / Q000139:chemically induced
D000305:Adrenal Cortex Hormones